Open Access
Publication ahead of print
Journal
Med Buccale Chir Buccale
Section Cas clinique et revue de la littérature / Up-to date review and case report
DOI https://doi.org/10.1051/mbcb/2016051
Published online 01 February 2017
  1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 1982;69(3):412-422. [CrossRef] [PubMed]
  2. Wassef M, Blei F, Adams D, Alomari A, Baselga E, Borenstein A. Vascular anomalies classifcation : recommendations from the international society for the study of vascular anomalies. Pediatrics 2015;136(1):e203-214. [CrossRef] [PubMed]
  3. Ernemann U, Kramer U, Miller S, Bisdas S, Rebmann H, Breuninger H, et al. Current concepts in the classification, diagnosis and treatment of vascular anomalies. Eur J Radiol 2010;75(1):2-11. [CrossRef] [PubMed]
  4. Mulligan PR, Prajapati HJS, Martin LG, Patel TH. Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches. Br J Radiol 2014;87(1035):20130392. [CrossRef] [PubMed]
  5. Ethunandan M, Mellor TK. Haemangiomas and vascular malformations of the maxillofacial region--a review. Br J Oral Maxillofac Surg 2006;44(4):263-272. [CrossRef] [PubMed]
  6. Bonet-Coloma C, Minguez-Martinez I, Aloy-Prosper A, Rubio-Serrana M, Penarrocha-Diago MA, Penarrocha-Diago M. Clinical characteristics, treatment and evolution in 14 cases of pediatric orofacial lymphangioma. J Oral Maxillofac Surg 2011;69:e96-99. [CrossRef] [PubMed]
  7. Brennan TD, Miller AS, Chen SY. Lymphangiomas of the oral cavity: a clinicopathologic, immunohistochemical, and electron-microscopic study. J Oral Maxillofac Surg 1997;55(9):932-935. [CrossRef] [PubMed]
  8. Nosher JL. Vascular anomalies: A pictorial review of nomenclature, diagnosis and treatment. World J Radiol 2014;6(9):677. [CrossRef] [PubMed]
  9. Zachariades N, Koundouris I. Lymphangioma of the oral cavity: report of a case. J Oral Med 1984;39(1):33-34. [PubMed]
  10. Wiegand S, Eivazi B, Barth PJ, von Rautenfeld DB, Folz BJ, Mandic R, et al. Pathogenesis of lymphangiomas. Virchows Arch 2008; 453(1):1-8. [CrossRef] [PubMed]
  11. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular. Development 1996; 122(12):3829-3837. [PubMed]
  12. Adams MT, Saltzman B, Perkins JA. Head and neck lymphatic malformation treatment: a systematic review. Otolaryngol Head Neck Surg 2012;147(4):627-639. [CrossRef]
  13. Riché MC. [Lymphangioma]. Rev Prat 1992;42(16):2041-2043. [PubMed]
  14. Enjolras O, Herbreteau D, Lemarchand F, Riche MC, Laurian C, Brette MD, et al. [Hemangiomas and superficial vascular malformations: classification]. J Mal Vasc 1992;17(1):2-19. [PubMed]
  15. Segado Arenas A, Flores González J-C, Rubio Quiñones F, Quintero Otero S, Hernández González A, Pantoja Rosso S. Obstruction iatrogène sévère de la voie aérienne par un lymphangiome lingual. Arch Pédiatrie 2011;18(9):983-986. [CrossRef]
  16. Zhou Q, Zheng JW, Mai HM, Luo QF, Fan XD, Su LX, et al. Treatment guidelines of lymphatic malformations of the head and neck. Oral Oncol 2011;47(12):1105-1109. [CrossRef] [PubMed]
  17. Turner C, Gross S. Treatment of recurrent suprahyoid cervicofacial lymphangioma with intravenous cyclophosphamide. Am J Pediatr Hematol Oncol 1994;16(4):325-328. [PubMed]
  18. Thottam PJ, Al-Barazi R, Madgy DN, Rozzelle A. Submucosal resection of a microcystic oropharyngeal lymphatic malformation using radiofrequency ablation. Int J Pediatr Otorhinolaryngol 2013; 77(9):1589-1592. [CrossRef]
  19. Pierrot S, Manach Y, Couloigner V. Lymphangiomes cervicofaciaux : imagerie, diagnostic et traitement. EMC - Oto-Rhino-Laryngol 2011;6(2):1-7. [CrossRef]
  20. Moser T, Chapot R, Jahn C, Salvador D, Baldi S, Beaujeux R. Imagerie des anomalies vasculaires des tissus mous : diagnostic et traitement. Feuill Radiol 2008;45(1):13-36. [CrossRef]
  21. Katsoulas N, Tosios KI, Argyris P, Koutlas IG, Sklavounou A. Lymphangioma circumscriptum, angiokeratoma, or superficial vascular ectasia with epithelial hyperplasia? Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118(2):e53-57. [CrossRef] [PubMed]
  22. Lavie A, Desouches C, Casanova D, Bardot J, Magalon G. Traitement chirurgical des malformations lymphatiques. Ann Chir Plast Esthét 2006;51(4-5):433-439. [CrossRef]
  23. Chakravarti A, Bhargava R. Lymphangioma circumscriptum of the tongue in children: successful treatment using intralesional bleomycin. Int J Pediatr Otorhinolaryngol 2013;77(8):1367-1369. [CrossRef]
  24. Acevedo JL, Shah RK, Brietzke SE. Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg 2008;138(4):418-424. [CrossRef]
  25. Colbert SD, Seager L, Haider F, Evans BT, Anand R, Brennan PA. Lymphatic malformations of the head and neck-current concepts in management. Br J Oral Maxillofac Surg 2013;51(2):98-102. [CrossRef] [PubMed]
  26. Mathur NN, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhinolaryngol 2005;69(1):75-80. [CrossRef]
  27. Won JH, Kim BM, Kim C-H, Park SW, Kim MD. Percutaneous sclerotherapy of lymphangiomas with acetic acid. J Vasc Interv Radiol 2004;15(6):595-600. [CrossRef] [PubMed]
  28. Churchill P, Otal D, Pemberton J, Ali A, Flageole H, Walton JM. Sclerotherapy for lymphatic malformations in children: a scoping review. J Pediatr Surg 2011;46(5):912-922. [CrossRef] [PubMed]
  29. Cable BB, Mair EA. Radiofrequency ablation of lymphangiomatous macroglossia. Laryngoscope 2001;111(10):1859-1861. [CrossRef] [PubMed]
  30. Leboulanger N, Roger G, Caze A, Enjolras O, Denoyelle F, Garabedian EN. Utility of radiofrequency ablation for haemorrhagic lingual lymphangioma. Int J Pediatr Otorhinolaryngol 2008; 72(7):953-958. [CrossRef]
  31. Reinhardt MA, Nelson SC, Sencer SF, Bostrom BC, Kurachek SC, Nesbit ME. Treatment of childhood lymphangiomas with interferon-alpha. J Pediatr Hematol Oncol 1997;19(3):232-236. [CrossRef] [PubMed]
  32. Timke C, Krause MF, Oppermann H-C, Leuschner I, Claviez A. Interferon alpha 2b treatment in an eleven-year-old boy with disseminated lymphangiomatosis. Pediatr Blood Cancer 2007;48(1):108-111. [CrossRef] [PubMed]
  33. Savas JA, Ledon J, Franca K, Chacon A, Zaiac M, Nouri K. Carbon dioxide laser for the treatment of microcystic lymphatic malformations (lymphangioma circumscriptum): a systematic review. Dermatol Surg 2013;39(8):1147-1157. [CrossRef] [PubMed]
  34. Sasaki R, Negishi K, Akita H, Suzuki K, Matsunaga K. Successful treatment of congenital lymphangioma circumscriptum of the vulva with CO2 and long-pulsed Nd:YAG Lasers. Case Rep Dermatol 2014;6(1):1-4. [CrossRef] [PubMed]
  35. Ozeki M, Fukao T, Kondo N. Propranolol for intractable diffuse lymphangiomatosis. N Engl J Med 2011;364(14):1380-1382. [CrossRef] [PubMed]
  36. Leboulanger N. Propranolol therapy for hemorrhagic lymphangioma of the tongue. Arch Otolaryngol Neck Surg 2011;137(8):813. [CrossRef]
  37. Maruani A, Brown S, Lorette G, Pondaven-Letourmy S, Herbreteau D, Eisenbaum A. Lack of effect of propranolol in the treatment of lymphangioma in two children. Pediatr Dermatol 2013;30(3):383-385. [CrossRef] [PubMed]